Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Pharmaceutics|February 25, 2023
A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug-Drug Interaction PerpetratorsFatima Zahra Marok, Jan-Georg Wojtyniak, Laura Maria Fuhr, et al.
European Journal of Clinical Pharmacology|June 2, 2011
Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based methodEleni Aklillu, Sabina Mugusi, Eliford Ngaimisi, et al.
British Journal of Clinical Pharmacology|June 7, 2013
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteersChristoph Markert, Yvonne Schweizer, Regina Hellwig, et al.
Clinical Pharmacology in Drug Development|January 4, 2024
Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's WortKatja S Gümüs, Anna Teegelbekkers, Max Sauter, et al.
British Journal of Clinical Pharmacology|July 10, 2003
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interactionJens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne, et al.
Journal of Clinical Pharmacology|November 27, 2008
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazoleJohanna Weiss, Magdalena Maria Ten Hoevel, Jürgen Burhenne, et al.
Clinical Pharmacology and Therapeutics|July 9, 2005
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokineticsJens Rengelshausen, Maria Banfield, Klaus-Dieter Riedel, et al.
Omics : a Journal of Integrative Biology|September 16, 2016
SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision MedicineEleni Aklillu, Abiy Habtewold, Eliford Ngaimisi, et al.
Pageof 19